HCK |
IPI00029769 |
BMX |
IPI00514142 |
78.260 |
Evidence |
|
BMX |
IPI00514142 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
78.260 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
78.260 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
78.260 |
Evidence |
|
MTF1 |
MTF1: Metal regulatory transcription factor 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
78.240 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CSK |
CSK: Tyrosine-protein kinase CSK |
78.230 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
78.230 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LYN |
LYN: Tyrosine-protein kinase Lyn |
78.230 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
78.090 |
Evidence |
|
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
DLG1 |
IPI00218729 |
77.970 |
Evidence |
|
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
77.910 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
77.910 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
77.910 |
Evidence |
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
FUBP1 |
IPI00375441 |
77.910 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
77.720 |
Evidence |
|
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
77.560 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
77.560 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
77.560 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
F12 |
F12: Coagulation factor XII precursor |
77.560 |
Evidence |
|
ALB |
ALB: Uncharacterized protein ALB |
C6 |
C6: Complement component C6 precursor |
77.560 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
77.560 |
Evidence |
O
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
77.560 |
Evidence |
|
COL1A1 |
COL1A1: Collagen alpha-1(I) chain precursor |
MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
77.560 |
Evidence |
O
|
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
77.560 |
Evidence |
|
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
77.560 |
Evidence |
|